Arbuckle Stuart A's Form 4 filing
Vertex Pharmaceuticals Inc (VRTX) · filed Feb 16, 2023
- Accession no.
- 0001209191-23-010050
- Filed
- Feb 16, 2023
- Trade date
- Feb 14, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions. Open-market sales total $1.91M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Arbuckle Stuart ACIK 0001557290 | Officer (EVP, COO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 14, 2023 | Common Stock | SSaleDisposed | −800 | $295.84F2,F3 | −$236,672 | 81,203 | Direct | |
| Feb 14, 2023 | Common Stock | SSaleDisposed | −901 | $296.85F2,F4 | −$267,461.85 | 80,302 | Direct | |
| Feb 14, 2023 | Common Stock | SSaleDisposed | −560 | $298.14F2,F5 | −$166,958.4 | 79,742 | Direct | |
| Feb 14, 2023 | Common Stock | SSaleDisposed | −2,003 | $299.13F2,F6 | −$599,157.39 | 77,739 | Direct | |
| Feb 14, 2023 | Common Stock | SSaleDisposed | −1,734 | $300.09F2,F7 | −$520,356.06 | 76,005 | Direct | |
| Feb 14, 2023 | Common Stock | SSaleDisposed | −400 | $300.89F2,F8 | −$120,356 | 75,605 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Referenced by the price of 6 transactions in Table I.
- F3
Open market sales reported on this line occurred at a weighted average price of $295.84 (range $295.34 to $296.20).
Referenced by the price of 1 transaction in Table I.
- F4
Open market sales reported on this line occurred at a weighted average price of $296.85 (range $296.49 to $297.30).
Referenced by the price of 1 transaction in Table I.
- F5
Open market sales reported on this line occurred at a weighted average price of $298.14 (range $297.59 to $298.57).
Referenced by the price of 1 transaction in Table I.
- F6
Open market sales reported on this line occurred at a weighted average price of $299.13 (range $298.68 to $299.60).
Referenced by the price of 1 transaction in Table I.
- F7
Open market sales reported on this line occurred at a weighted average price of $300.09 (range $299.73 to $300.70).
Referenced by the price of 1 transaction in Table I.
- F8
Open market sales reported on this line occurred at a weighted average price of $300.89 (range $300.78 to $301.03).
Referenced by the price of 1 transaction in Table I.